article thumbnail

'The Top Line': A look at pharma revenue rankings

Fierce Pharma

Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Staff Writer Kevin Dunleavy are diving into our annual top pharma companies by revenue special report.

Pharma 130
article thumbnail

Using AI to Become Pharma's Next Superhero

Fierce Pharma

“AI is becoming part of the pharma fabric, and it really is set to disrupt the industry.” | Viz.ai’s Nina Binetti is joined by colleagues at CrowdPharm and Remedy Product Studio to explore the various ways in which AI is being used among pharma companies – from improving patient diagnoses and treatments to unlocking operating efficiencies.

Pharma 301
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Executive Interviews at Digital Pharma East 2023

Fierce Pharma

Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Fierce Pharma sits down with digital marketing leaders to discuss this year's most innovative topics at Digital Pharma East. Learn more by watching the videos below.

Pharma 246
article thumbnail

Gilead cuts 7% of staff at Kite Pharma unit as 'refreshed business strategy' introduced

Fierce Pharma

Gilead Sciences' Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce. Gilead’s Kite Pharma cell therapy unit is undergoing a business review that will result in layoffs to about 7% of the organization’s workforce.

Pharma 330
article thumbnail

With exec appointments and new pharma unit, Bayer's overhaul takes shape

Fierce Pharma

In the pharma sector, Bayer revealed a new Global Commercialization unit, which will be led by Christine Roth. .” | Early this month at an investor event, Bayer CEO Bill Anderson declared that employees “are ready for change." " On Wednesday, Anderson answered the call with changes to the company’s leadership.

Pharma 276
article thumbnail

Fierce Pharma Asia—Big Pharma's China visit; AstraZeneca's parallel supply chains; WuXi's predicament

Fierce Pharma

Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. Several Big Pharma CEOs gathered in Beijing to reaffirm their commitment to the Chinese market. AstraZeneca is working to separate its supply chains for the U.S. AstraZeneca is working to separate its supply chains for the U.S. and China.

Pharma 130
article thumbnail

2024 forecast: Big Pharma reworks China strategy, and job cuts are part of it

Fierce Pharma

Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.

Pharma 315